SPL 4.35% 11.0¢ starpharma holdings limited

leave the conversation to the adults sarge. But for your benefit...

  1. bid
    577 Posts.
    lightbulb Created with Sketch. 140
    leave the conversation to the adults sarge. But for your benefit I guess, I said but not in so many words, in the cohort of participants over the age of 45 the primary end point of the study was met. In fact for 118 participants a p value of 0.017 was demonstrated. Thats 1.7% chance the effect was due to chance or for 98.3% of the time the end point of the study was met. Further, too many people under the age of 45 didn’t complete the study. IMO likely became well and stopped treatment before trial end. Unfortunately this affected the overall end result since that cohort represented 40% of participants. You claim to represent the truth. There it is.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
11.0¢
Change
-0.005(4.35%)
Mkt cap ! $45.32M
Open High Low Value Volume
11.5¢ 11.5¢ 11.0¢ $70.99K 620.9K

Buyers (Bids)

No. Vol. Price($)
10 337138 11.0¢
 

Sellers (Offers)

Price($) Vol. No.
12.0¢ 116759 6
View Market Depth
Last trade - 16.10pm 17/05/2024 (20 minute delay) ?
Last
11.5¢
  Change
-0.005 ( 0.00 %)
Open High Low Volume
11.5¢ 11.5¢ 11.0¢ 165069
Last updated 15.30pm 17/05/2024 ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.